Aprevo is an FDA-designated breakthrough device that is patient-specific. It’s also designated as a transformative new device by Medicare.
“Offering Aprevo to our patients represents an important step to advancing surgical outcomes in spinal care and exemplifies our commitment to offering our patients the best care possible,” said Roland Kent, MD, co-owner of the hospital and co-founder of Northwest Specialty Hospital’s Axis Spine Center in Coeur d’Alene, Idaho.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
